NewsGenomics

Whitehead, Three Firms Splice a Deal

Science  09 May 1997:
Vol. 276, Issue 5314, pp. 891
DOI: 10.1126/science.276.5314.891a

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

CAMBRIDGE, MASSACHUSETTS-- An unusual new consortium of companies has joined Eric Lander, a gene mapper at the Whitehead Institute for Biomedical Research and the Massachusetts Institute of Technology, in a 5-year, $40 million effort to develop new "functional genomics" techniques. New Jersey-based pharmaceuticals giant Bristol-Myers Squibb, "DNA chip"-maker Affymetrix Inc. of Santa Clara, California, and Millennium Pharmaceuticals of Cambridge, Massachusetts, will give the center equal amounts of cash and equipment for research into faster, more efficient ways to gather and compare genetic data. In return, the companies will get commercial rights to technologies developed under the program.

Related Content